FDA
-
Migraine Prevention Drug Receives FDA Approval: Aimovig By Amgen Is The First Of Its Kind
-
FDA Approves Lucemyra, The First Non-Opioid Drug For Opioid Withdrawal Symptoms Up To 14 Days
-
FDA Warns Of EpiPen Shortage: How To Be Prepared When You Need An Emergency Allergy Shot
-
E-Cigarette Use In Classrooms Plummets, FDA Tries To Prevent Sales To Minors
-
Marijuana-Based Drug For Seizures Gets Unanimous Recommendation From FDA Committee
-
A Seizure Drug Made From Marijuana Is This Close To Getting FDA Approval
-
FDA Issues First Ever Mandatory Recall For Contaminated Food: Kratom Products With Salmonella
-
FDA Cracks Down On Salt Intake, Redefines What ‘Healthy’ Labels Mean
-
FDA Takes Action To Regulate Flavors In Cigarettes
-
FDA Plans To Lower Nicotine Content In Cigarettes To Non-Addictive Levels
-
The FDA Is Taking Steps To Combat Opioid Addiction, Plans Expanded Access To Medication-Assisted Therapy
-
Antibiotic Clarithromycin Can Potentially Raise Risk Of Death In Patients With Heart Disease
Most Popular
